Literature DB >> 25739654

UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo.

Ana Tiganescu1, Melanie Hupe, Yan J Jiang, Anna Celli, Yoshikazu Uchida, Theodora M Mauro, Daniel D Bikle, Peter M Elias, Walter M Holleran.   

Abstract

Detrimental consequences of ultraviolet radiation (UVR) in skin include photoageing, immunosuppression and photocarcinogenesis, processes also significantly regulated by local glucocorticoid (GC) availability. In man, the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) generates the active GC cortisol from cortisone (or corticosterone from 11-dehydrocorticosterone in rodents). 11β-HSD1 oxo-reductase activity requires the cofactor NADPH, generated by hexose-6-phosphate dehydrogenase. We previously demonstrated increased 11β-HSD1 levels in skin obtained from photoexposed versus photoprotected anatomical regions. However, the direct effect of UVR on 11β-HSD1 expression remains to be elucidated. To investigate the cutaneous regulation of 11β-HSD1 following UVR in vivo, the dorsal skin of female SKH1 mice was irradiated with 50, 100, 200 and 400 mJ/cm(2) UVB. Measurement of transepidermal water loss, 11β-HSD1 activity, mRNA/protein expression and histological studies was taken at 1, 3 and 7 days postexposure. 11β-HSD1 and hexose-6-phosphate dehydrogenase mRNA expression peaked 1 day postexposure to 400 mJ/cm(2) UVB before subsequently declining (days 3 and 7). Corresponding increases in 11β-HSD1 protein and enzyme activity were observed 3 days postexposure coinciding with reduced GC receptor mRNA expression. Immunofluorescence studies revealed 11β-HSD1 localization to hyperproliferative epidermal keratinocytes in UVB-exposed skin. 11β-HSD1 expression and activity were also induced by 200 and 100 (but not 50) mJ/cm(2) UVB and correlated with increased transepidermal water loss (indicative of barrier disruption). UVB-induced 11β-HSD1 activation represents a novel mechanism that may contribute to the regulation of cutaneous responses to UVR exposure.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  11β-hydroxysteroid dehydrogenase type 1; UVB; glucocorticoid; skin; transepidermal water loss

Mesh:

Substances:

Year:  2015        PMID: 25739654      PMCID: PMC6365099          DOI: 10.1111/exd.12682

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  10 in total

Review 1.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

2.  The significance of CYP11A1 expression in skin physiology and pathology.

Authors:  R M Slominski; C Raman; C Elmets; A M Jetten; A T Slominski; R C Tuckey
Journal:  Mol Cell Endocrinol       Date:  2021-03-12       Impact factor: 4.369

3.  Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.

Authors:  Nicola Cirillo; David J Morgan; Maria Carmela Pedicillo; Antonio Celentano; Lorenzo Lo Muzio; Michael J McCullough; Stephen S Prime
Journal:  Br J Cancer       Date:  2017-08-10       Impact factor: 7.640

4.  Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis.

Authors:  Mototsugu Fukaya
Journal:  Indian J Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.494

5.  Psychological Stress Deteriorates Skin Barrier Function by Activating 11β-Hydroxysteroid Dehydrogenase 1 and the HPA Axis.

Authors:  Sung Jay Choe; Donghye Kim; Eun Jung Kim; Joung-Sook Ahn; Eun-Jeong Choi; Eui Dong Son; Tae Ryong Lee; Eung Ho Choi
Journal:  Sci Rep       Date:  2018-04-20       Impact factor: 4.379

6.  Evaluation of 11-β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band-UVB phototherapy.

Authors:  Linda Tognetti; Francesco Damiani; Camilla Marrocco; Giancarlo Mariotti; Emanuele Trovato; Elisa Cinotti; Paola Marcolongo; Michele Pellegrino; Pietro Rubegni
Journal:  Photodermatol Photoimmunol Photomed       Date:  2021-11-18       Impact factor: 3.254

7.  A novel mineralocorticoid receptor antagonist, 7,3',4'-trihydroxyisoflavone improves skin barrier function impaired by endogenous or exogenous glucocorticoids.

Authors:  Hanil Lee; Eun-Jeong Choi; Eun Jung Kim; Eui Dong Son; Hyoung-June Kim; Won-Seok Park; Young-Gyu Kang; Kyong-Oh Shin; Kyungho Park; Jin-Chul Kim; Su-Nam Kim; Eung Ho Choi
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

8.  Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 Contributes to Epidermal Permeability Barrier Dysfunction in Aged Skin.

Authors:  Beom Jun Kim; Noo Ri Lee; Chung Hyeok Lee; Young Bin Lee; Sung Jay Choe; Solam Lee; Hyun Jee Hwang; Eunjung Kim; Gareth G Lavery; Kyong-Oh Shin; Kyungho Park; Eung Ho Choi
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

9.  Local cortisol activation is involved in EGF-induced immunosuppression.

Authors:  Sayaka Matsumura; Mika Terao; Satoshi Itami; Ichiro Katayama
Journal:  Dermatoendocrinol       Date:  2017-12-26

10.  Role of 11β-hydroxysteroid dehydrogenase type 1 in the development of atopic dermatitis.

Authors:  Noo Ri Lee; Beom Jun Kim; Chung Hyeok Lee; Young Bin Lee; Solam Lee; Hyun Jee Hwang; Eunjung Kim; Sung Hee Kim; Min-Geol Lee; Sang Eun Lee; Gareth G Lavery; Eung Ho Choi
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.